These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 19358898)

  • 1. A comparative analysis of binding sites between mouse CYP2C38 and CYP2C39 based on homology modeling, molecular dynamics simulation and docking studies.
    Meng XY; Zheng QC; Zhang HX
    Biochim Biophys Acta; 2009 Jul; 1794(7):1066-72. PubMed ID: 19358898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid.
    Luo G; Zeldin DC; Blaisdell JA; Hodgson E; Goldstein JA
    Arch Biochem Biophys; 1998 Sep; 357(1):45-57. PubMed ID: 9721182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
    Sun B; Song S; Hao CZ; Huang WX; Liu CC; Xie HL; Lin B; Cheng MS; Zhao DM
    J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding.
    Gomaa MS; Yee SW; Milbourne CE; Barbera MC; Simons C; Brancale A
    J Enzyme Inhib Med Chem; 2006 Aug; 21(4):361-9. PubMed ID: 17059167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice.
    Andreola F; Hayhurst GP; Luo G; Ferguson SS; Gonzalez FJ; Goldstein JA; De Luca LM
    J Biol Chem; 2004 Jan; 279(5):3434-8. PubMed ID: 14623888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products.
    DeLozier TC; Tsao CC; Coulter SJ; Foley J; Bradbury JA; Zeldin DC; Goldstein JA
    J Pharmacol Exp Ther; 2004 Sep; 310(3):845-54. PubMed ID: 15084647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regioselectivity of CYP2B6: homology modeling, molecular dynamics simulation, docking.
    Bathelt C; Schmid RD; Pleiss J
    J Mol Model; 2002 Nov; 8(11):327-35. PubMed ID: 12483228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in cytochrome P450 active site modeling.
    Kemp CA; Maréchal JD; Sutcliffe MJ
    Arch Biochem Biophys; 2005 Jan; 433(2):361-8. PubMed ID: 15581592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modeling, binding site identification and docking in flavone hydroxylase CYP105P2 in Streptomyces peucetius ATCC 27952.
    Kanth BK; Liou K; Sohng JK
    Comput Biol Chem; 2010 Aug; 34(4):226-31. PubMed ID: 20889382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of human cytochrome P450 2W1 and its interactions with substrates.
    Li W; Tang Y; Hoshino T; Neya S
    J Mol Graph Model; 2009 Sep; 28(2):170-6. PubMed ID: 19596602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
    Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H
    Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4.
    Szklarz GD; He YQ; Kedzie KM; Halpert JR; Burnett VL
    Arch Biochem Biophys; 1996 Mar; 327(2):308-18. PubMed ID: 8619620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.
    Lewis DF
    J Inorg Biochem; 2002 Sep; 91(4):502-14. PubMed ID: 12237218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions.
    Lewis DF; Lake BG; Dickins M; Goldfarb PS
    Xenobiotica; 2004 Jun; 34(6):549-69. PubMed ID: 15277015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology modeling of human 25-hydroxyvitamin D3 1alpha-hydroxylase (CYP27B1) based on the crystal structure of rabbit CYP2C5.
    Yamamoto K; Masuno H; Sawada N; Sakaki T; Inouye K; Ishiguro M; Yamada S
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):167-71. PubMed ID: 15225767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the CYP3A4 active site by homology modeling.
    Tanaka T; Okuda T; Yamamoto Y
    Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):830-5. PubMed ID: 15256703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization, modeling and docking of CYP107CB2 from Bacillus lehensis G1, an alkaliphile.
    Ang SS; Salleh AB; Chor AL; Normi YM; Tejo BA; Rahman MB
    Comput Biol Chem; 2015 Jun; 56():19-29. PubMed ID: 25766878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions.
    Sheng C; Zhang W; Zhang M; Song Y; Ji H; Zhu J; Yao J; Yu J; Yang S; Zhou Y; Zhu J; Lu J
    J Biomol Struct Dyn; 2004 Aug; 22(1):91-9. PubMed ID: 15214809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation.
    Shahlaei M; Madadkar-Sobhani A; Mahnam K; Fassihi A; Saghaie L; Mansourian M
    Biochim Biophys Acta; 2011 Mar; 1808(3):802-17. PubMed ID: 21167131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling and docking studies of Streptomyces peucetius CYP147F1 as limonene hydroxylase.
    Bhattarai S; Liou K; Oh TJ
    J Microbiol Biotechnol; 2012 Jul; 22(7):917-22. PubMed ID: 22580310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.